Cite
HARVARD Citation
Kasi, P. et al. (2022). BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours. BMJ open. 12 (5), p. . [Online].